Paragraph 5

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Sch 3, Pt II, para 1 am by Medicines (Products for Animal Use—Fees) 2001 regs 2(3)(a), 3
Sch 3, Pt II, para 2 am by Medicines (Products for Animal Use—Fees) 2001 regs 2(3)(b), 3
Sch 3, Pt III am by Medicines (Products for Animal Use—Fees) 2001 regs 2(3)(c), 3
Sch.3, Pt.II, para.1 amended by Medicines (Products for Animal Use—Fees) 1999 reg.3(1)(a)
Sch.3, Pt.II, para.2 amended by Medicines (Products for Animal Use—Fees) 1999 reg.3(1)(b)
Sch.3, Pt.III amended by Medicines (Products for Animal Use—Fees) 1999 reg.3(1) (c)
regs 12,13.14. Sch 1. Pt.II, paras.1 -3,6-9, Pt.III. paras 4,5, Pt.IV, paras.1- 3,5-7, Pt.V, paras.1 -3. Sch.2. paras.2.3 amended by Medicines (Products for Animal Use—Fees) 2000 reg.2. Sch.
Sch.3, Pt.II, para.2 amended by Medicines (Products for Animal Use—Fees) 2000 reg.3(1)(b)
Sch.3, Pt.III amended by Medicines (Products for Animal Use—Fees) 2000 reg.3(1)(c)
Sch 3, Pt II, para 1 am by Medicines (Products for Animal Use—Fees) 2003 regs 3(1), (3), 4
Sch 3, Pt II am by Medicines (Products for Animal Use—Fees) 2002 regs 2(2), 3

If a marketing authorisation or product licence holder does not submit evidence of turnover in relation to the relevant calendar year to the satisfaction of the relevant authority, the annual fee payable by him for that year shall be the sum of £10,000 together with an additional £2,000 for each description of product in respect of which a marketing authorisation or product licence is held by the authorisation or licence holder.